ATP13A2 and Parkinson disease: Additionally, mutations in ATP13A2, also known as PARK9, which is a gene associated with autosomal recessive forms of early-onset PD, result in the dysregulation of Zn2+ homeostasis, thereby promoting lysosomal dysfunction and α-synuclein accumulation [55,56,57,58].